Sandbox : anmol: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 15: | Line 15: | ||
==Creating tables== | ==Creating tables== | ||
{| | {| | ||
!colspan="4" style="background:#4479BA; color: #FFFFFF;" + |Wiki | ! colspan="4" style="background:#4479BA; color: #FFFFFF;" + |Wiki | ||
|- | |- | ||
|rowspan="2" style="background:#DCDCDC;" align="center" + |GSD type 1 | | rowspan="2" style="background:#DCDCDC;" align="center" + |GSD type 1 | ||
| style="background:#F5F5F5;"+ |GSD type 1a | | style="background:#F5F5F5;" + |GSD type 1a | ||
| style="background:#F5F5F5;"+ |AR | | style="background:#F5F5F5;" + |AR | ||
| style="background:#F5F5F5;"+ |hypoglycemia | | style="background:#F5F5F5;" + |hypoglycemia | ||
|- | |- | ||
| style="background:#F5F5F5;"+ |GSD type 1b | | style="background:#F5F5F5;" + |GSD type 1b | ||
| style="background:#F5F5F5;"+ |AR | | style="background:#F5F5F5;" + |AR | ||
| style="background:#F5F5F5;"+ |hypoglycemia | | style="background:#F5F5F5;" + |hypoglycemia | ||
|} | |||
{| class="wikitable" | |||
|+ Classification | |||
!colspan="2" |UMN leasion | |||
!colspan="2" |LMN lesion | |||
|- | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | |||
| | |||
| | |||
|} | |} | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 16:00, 1 November 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Creating Algorihm
| MI | |||||||||||||||||||||||||||
| STEMI | NSTEMI | ||||||||||||||||||||||||||
Creating tables
| Wiki | |||
|---|---|---|---|
| GSD type 1 | GSD type 1a | AR | hypoglycemia |
| GSD type 1b | AR | hypoglycemia | |
| UMN leasion | LMN lesion | ||
|---|---|---|---|